Ethanol increases the interstitial dopamine (DA) concentration in the nucleus accumbens (NAcc) of experimental animals, but positron emission tomography (PET) studies using the single-bolus protocol of the [ 11 C]-raclopride competition paradigm have yielded conflicting results in humans. To resolve disparate previous findings, we utilized the bolus-plus-infusion (B/I) method, allowing both baseline and intervention quantification of [ 11 C]raclopride binding during a single 105-minute PET scan, to investigate possible ethanol-induced DA release in nine healthy male subjects. A 25-minute intravenous ethanol (7.6%) infusion, resulting in a 1.3 g/L mean blood ethanol concentration, was administered using masked timing during the PET scan. Automated region-of-interest analysis testing the difference between baseline (40-50 minutes) and intervention (60-85 minutes) revealed an average 12.6% decrease in [ 11 C]raclopride binding in the ventral striatum (VST, P = 0.003) including the NAcc. In addition, a shorter time interval from the start of ethanol infusion to the first subjective effect was associated with a greater binding potential decrease bilaterally in the VST (r = 0.92, P = 0.004), and the feeling of pleasure was associated with a decrease in binding potential values in both the caudate nucleus (r = − 0.87, P = 0.003) and putamen (r = − 0.74; P = 0.02). These results confirm that ethanol induces rapid DA release in the limbic striatum, which can be reliably estimated using the B/I method in one imaging session. Previous PET studies exploring the effects of acute alcohol intervention on DA neurotransmission in humans have yielded conflicting results. The first [ 11 C]raclopride PET study applying oral alcohol administration did not show any effect, 3 but in a later study decreased [ 11 C]raclopride binding was shown, suggesting an increased DA concentration in the VST, although the effect varied considerably among the subjects. 4 Two studies using prolonged stable intravenous ethanol infusion during PET data